Ann: 3,250 Prescriptions Milestone Surpassed, page-33

Does anyone know why Dr Wendyl De Souza no longer seems to be part of the MGC Pharma medical advisory board?

There doesn't seem to any mention of links between the two any more?

Dr De Souza was spruiked as the epilepsy messiah with the link to all the potential CannEpil patients that were going to bring in the 'millions' in revenue. What happened?

Did he wake up to what MXC are really about and ran a mile or Is this one of the 'agreements' or 'research' MXC decided was not 'essential' and therefore cancelled the arrangement?

Another case of the appointment being hailed as 'price sensitive' and great news that brought no real value for MXC holders and another partnership that has gone by the wayside without so much as a mention from the company.

I would be interested to hear if anyone knows anymore about what happened or have asked the company about this?